You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

teclistamab

Showing 1 - 13 of 13
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Myeloma Trial (Teclistamab, Daratumumab, Lenalidomide)

Not yet recruiting
  • Multiple Myeloma
  • Teclistamab
  • +2 more
  • (no location specified)
Oct 6, 2022

Relapsed or Refractory Multiple Myeloma Trial in Dummy (Teclistamab)

Available
  • Relapsed or Refractory Multiple Myeloma
  • Teclistamab
  • Dummy, France
  • +2 more
Aug 10, 2022

High-Risk de Novo Multiple Myeloma Trial in Spain (Daratumumab, Bortezomib, Lenalidomide)

Not yet recruiting
  • High-Risk de Novo Multiple Myeloma
  • Badalona, Spain
  • +9 more
Apr 27, 2023

Multiple Myeloma Trial in Worldwide (Talquetamab, Teclistamab, Daratumumab)

Recruiting
  • Multiple Myeloma
  • Edmonton, Alberta, Canada
  • +12 more
Jan 27, 2023

Multiple Myeloma Trial in Worldwide (Teclistamab, Lenalidomide)

Not yet recruiting
  • Multiple Myeloma
  • Melbourne, Australia
  • +13 more
Feb 7, 2022

Multiple Myeloma Trial in Worldwide (Teclistamab, Daratumumab, Pomalidomide)

Active, not recruiting
  • Multiple Myeloma
  • Teclistamab
  • +5 more
  • Birmingham, Alabama
  • +26 more
Jan 17, 2023

High-risk Smoldering Multiple Myeloma, Smoldering Multiple Myeloma, Multiple Myeloma Trial in Boston (Teclistamab, Lenalidomide,

Recruiting
  • High-risk Smoldering Multiple Myeloma
  • +2 more
  • Teclistamab
  • +2 more
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Aug 11, 2022

Hematologic Malignancies Trial in Japan (Teclistamab)

Recruiting
  • Hematologic Malignancies
  • Teclistamab
  • Chiba, Japan
  • +14 more
Aug 11, 2022

Relapsed/ Refractory Multiple Myeloma Trial in Worldwide (Talquetamab, Teclistamab, PD-1 Inhibitor)

Recruiting
  • Relapsed/ Refractory Multiple Myeloma
  • Denver, Colorado
  • +19 more
Jan 27, 2023

Hematological Malignancies Trial in Worldwide (Teclistamab)

Recruiting
  • Hematological Malignancies
  • Teclistamab
  • Birmingham, Alabama
  • +80 more
Jan 27, 2023

Relapsed or Refractory Multiple Myeloma Trial in Worldwide (Teclistamab, Pomalidomide, Bortezomib)

Recruiting
  • Relapsed or Refractory Multiple Myeloma
  • Teclistamab
  • +4 more
  • Berkeley, California
  • +188 more
Jan 27, 2023

Multiple Myeloma Trial in Worldwide (Daratumumab, Pomalidomide, Dexamethasone)

Recruiting
  • Multiple Myeloma
  • Birmingham, Alabama
  • +198 more
Jan 17, 2023

Multiple Myeloma Trial in Worldwide (Teclistamab, Daratumumab, Lenalidomide)

Recruiting
  • Multiple Myeloma
  • Teclistamab
  • +3 more
  • Tucson, Arizona
  • +189 more
Jan 27, 2023